
|Videos|December 14, 2021
Dr. Kutikov discusses recent NCCN guideline reversal on active surveillance
Author(s)Urology Times staff
“Seeing the social media chatter, I think there is tremendous support for walking this back,” says Alexander Kutikov, MD, FACS.
Advertisement
In this video, Alexander Kutikov, MD, FACS, discusses the recent National Comprehensive Cancer Network guideline reversal regarding active surveillance in men with low-risk prostate cancer. Kutikov is the chief of the division of urology and urologic oncology, professor in the department of surgical oncology, and the Roberta R. Scheller Chair in urologic oncology at the Fox Chase Cancer Center at Temple University in Philadelphia, Pennsylvania.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Dosing begins in trial of alpha radioligand therapy for mCRPC
2
Novel tool may help predict early PSA response to ARPIs in mHSPC
3
Fed Ghali, MD, highlights trial of consolidative local therapy following EV/P
4
RCMIGI trial supports feasibility of reduced margins in image-guided prostate radiotherapy
5



















